Xilio Therapeutics
Xilio is a Waltham, Massachusetts-based clinical-stage biopharmaceutical company focused on defeating cancer.
Website
Headquarters
828 Winter Street, Suite 300 Waltham, MA 02451, USA
Company Size
50 - 99
-
NOV 01, 2020
The ICIS Annual Meetings typically attract 650-750 registrants and have a distinguished history of presenting cutting edge research from internationally recognized scientists. This meeting e...
-
APR 30, 2024Immuno-Oncology Virtual Event Series 2024
-
MAY 07, 20243rd International Biosecurity Virtual Symposium
-
SEP 03, 2024Microbiology Week Virtual Event Series 2024
- See More
